19Jun
Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G BioHealth Sells Vertiflex to Boston Scientific
H.I.G. BioHealth Partners, the life-science investment affiliate of H.I.G. Capital, has announced the sale of Vertiflex to Boston Scientific. The total equity value of the sale is approximately $465 million in cash, with additional payments...
By:
McGuireWoods LLP
Related
On February 2, 2021, the Federal Trade Commission (FTC) published its adjusted reporting thresholds ...
Read More >
IN BRIEF - The sale of a family business or any business with multiple owners creates potential co...
Read More >
2019 ends with a bang. Even apart from that big political event that begins with the "I" word, and ...
Read More >
United States District Judge James M. Moody (“Court”) addressed in a September 3rd Order a July 10...
Read More >
Judicial Panel on Multidistrict Litigation Centralizes Some COVID‐19 Related Insurance Cases As rep...
Read More >
The IRS has just issued the cost of living adjustments for various retirement plan limitations that ...
Read More >